Biotech & Pharma

The healthcare industry is dynamic and complex.  No other industry raises more hopes in the human and financial dimensions.

In over two dozen transactions and disputes in this area I have gained an understanding of the structures and interests in the field from the point of view of founders and investors as well as from a regulatory viewpoint. Seen the tactics of small and large players. Taken apart the interconnection of science, operational necessities and strategy to achieve a legal framework for the client.

The medical technologies I have experience with include:

• Platform technologies
• NCEs
• Biologics
• Drug delivery systems
• Medical devices
• Generics

for use as

• Therapeutics
• Prophylactics
• Diagnostics
• R&D tools

in the indications

• Benign tumors
• Malignant tumors
• Cardiac disease
• Renal damage
• Heriditary neurodegenerative disease
• Diabetes
• Pulmonary disease
• Pain relief
• Tissue regeneration
• Allergies
• Infections

with regulatory approval proceedings before the

• FDA
• EMEA
• European national agencies including Switzerland

as well as in

• Eastern Europe and
• Asia

with clinical trials worldwide, in some cases under Orphan-Drug and Fast-Track–Programs

for clients who are

• Start-up-companies
• Speciality Pharma companies
• Big Pharma
• VCs
• Private Equity
• Banks

in

• IPOs
• Stock Exchange Listings
• Private Placements
• Acquisitions
• Joint Venture-Dissolutions
• Asset sales
• Private equity investments
• Licenses
• R&D and
• Distribution contracts
• as well as legal disputes.

I enjoy every opportunity to use and expand my experience in this exciting field.